150. Low Propensity for Development of Spontaneous In Vitro Resistance to Tebipenem, Ertapenem and Meropenem Among Enterobacterales Uropathogens

por VanScoy, Brian D, Conde, Haley, Mendes, Rodrigo E, Cotroneo, Nicole, Critchley, Ian A, Critchley, Ian A
Publicado 2022

2068. Evaluation of Ceftazidime-Avibactam Disks from Different Commercial Manufacturers for Susceptibility Testing against Meropenem Nonsusceptible Enterobacteriaceae

por Lin, Lynn-Yao, Critchley, Ian A
Publicado 2018

2236. Effectiveness of TBP-PI-HBr in Patients with Instrumentation, Anatomic or Functional Abnormalities: Secondary Analysis from ADAPT-PO

por Talley, Angela K, Eckburg, Paul B, Critchley, Ian A, Critchley, Ian A, Moore, Gary E, Bhatt, Nivedita, Muir, Lori A, Muir, Lori A, Melnick, David
Publicado 2022

The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017

por Critchley, Ian A., Cotroneo, Nicole, Pucci, Michael J., Mendes, Rodrigo
Publicado 2019

1465. Resistance to Oral Antibiotics Among Urinary Tract Infection Isolates of Escherichia coli from the United States and Europe in 2017

por Critchley, Ian A, Cotroneo, Nicole, Sulham, Kate, Melnick, David, Mendes, Rodrigo E
Publicado 2019

1695. Tebipenem: An Oral Carbapenem with activity against Multi-drug Resistant Urinary Tract Infection isolates of Escherichia coli collected from US Medical Centers during 2019

por Critchley, Ian A, Cotroneo, Nicole S, Pucci, Michael J, Jain, Akash, Mendes, Rodrigo E
Publicado 2020

1044. In vitro Activity of Tebipenem Against Relevant Clinical Isolates in the Presence of Pulmonary Surfactant

por Arends, S J Ryan, Klauer, Abby L, Cotroneo, Nicole, Critchley, Ian A, Mendes, Rodrigo E
Publicado 2021

1041. In vitro activity of tebipenem against a recent collection of fastidious organisms recovered from respiratory tract infections

por Arends, S J Ryan, Klauer, Abby L, Cotroneo, Nicole, Critchley, Ian A, Mendes, Rodrigo E
Publicado 2021

1038. In Vitro Activity of Tebipenem, an Orally Available Carbapenem Agent, Against a Collection of Surveillance Gram-Positive Clinical Isolates

por Arends, S J Ryan, Klauer, Abby L, Cotroneo, Nicole, Critchley, Ian A, Mendes, Rodrigo E
Publicado 2021

1057. Tebipenem In vitro Activity Against a Collection of Pathogens Responsible for Urinary Tract Infections in the US

por Mendes, Rodrigo E, Critchley, Ian A, Cotroneo, Nicole, Streit, Jennifer M, Sader, Helio S, Castanheira, Mariana, Castanheira, Mariana
Publicado 2021

1281. An Evaluation of Tebipenem In Vitro Activity Against a Panel of Pseudomonas aeruginosa Isolates with Efflux, AmpC, and OprD Mutations

por VanScoy, Brian D, Conde, Haley, Cotroneo, Nicole, Critchley, Ian A, Parr, Thomas R, Ambrose, Paul G
Publicado 2021

1254. Molecular Epidemiology of Escherichia coli Causing Urinary Tract Infections in United States and in vitro Activity of Tebipenem, Including Against Strain Lineage and Resistan...

por Mendes, Rodrigo E, Doyle, Timothy B, Critchley, Ian A, Cotroneo, Nicole, Streit, Jennifer M, Castanheira, Mariana, Castanheira, Mariana
Publicado 2021

1095. Pharmacokinetics-Pharmacodynamics Evaluation of Tebipenem Pivoxil Hydrobromide Using the 10-Day Hollow-Fiber In Vitro Infection Model

por VanScoy, Brian D, Conde, Haley, Jones, Sean, Critchley, Ian A, Parr, Thomas R, Cotroneo, Nicole, Ambrose, Paul G
Publicado 2021

Randomized Trial of Ceftazidime-Avibactam vs Meropenem for Treatment of Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (REPROVE): Analyses per US FDA–Specified End...

por Torres, Antoni, Rank, Doug, Melnick, David, Rekeda, Ludmyla, Chen, Xiang, Riccobene, Todd, Critchley, Ian A, Lakkis, Hassan D, Taylor, Dianna, Talley, Angela K
Publicado 2019

1304. Characterization of Tebipenem Pivoxil Hydrobromide Pharmacokinetics-Pharmacodynamics (PK-PD) in a Neutropenic Murine Acute Pyelonephritis (AP) Model

por VanScoy, Brian D, Fikes, Steven, Rubino, Christopher M, Bhavnani, Sujata M, Cotroneo, Nicole S, Critchley, Ian A, Parr, Thomas R, Ambrose, Paul G
Publicado 2020

1565. Characterization of Tebipenem (SPR859) Pharmacokinetics–Pharmacodynamics (PK-PD) for Efficacy Against Enterobacteriaceae in a One-Compartment In Vitro Infection Model

por VanScoy, Brian D, Onufrak, Nikolas J, Conde, Haley, Caranco, Ana I, Bhavnani, Sujata M, Cotroneo, Nicole, Critchley, Ian A, Parr, Thomas R, Ambrose, Paul G
Publicado 2019

Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections

por Melnick, David, Talley, Angela K., Gupta, Vipul K., Critchley, Ian A., Eckburg, Paul B., Hamed, Kamal A., Bhatt, Nivedita, Moore, Gary, Austin, Daren, Rubino, Christopher M., Bhavnani, Sujata M., Ambrose, Paul G.
Publicado 2023